Tracon Pharmaceuticals Stock Technical Analysis

TCON Stock  USD 0.41  0.02  4.65%   
As of the 28th of March, TRACON Pharmaceuticals owns the downside deviation of 9.8, and Risk Adjusted Performance of 0.1031. In relation to fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of TRACON Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the company will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for TRACON Pharmaceuticals, which can be compared to its peers in the sector. Please validate TRACON Pharmaceuticals variance, as well as the relationship between the value at risk and skewness to decide if TRACON Pharmaceuticals is priced more or less accurately, providing market reflects its prevailing price of 0.41 per share. As TRACON Pharmaceuticals is a penny stock we also advise to double-check its total risk alpha numbers.

TRACON Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as TRACON, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to TRACON
  
TRACON Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

TRACON Pharmaceuticals Analyst Consensus

Target PriceAdvice# of Analysts
5.33Buy2Odds
TRACON Pharmaceuticals current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most TRACON analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand TRACON stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of TRACON Pharmaceuticals, talking to its executives and customers, or listening to TRACON conference calls.
TRACON Analyst Advice Details
TRACON Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of TRACON Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of TRACON Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

TRACON Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of TRACON Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

TRACON Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for TRACON Pharmaceuticals. You can use it to identify possible trend reversals for TRACON Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual TRACON Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

TRACON Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for TRACON Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of    , which means TRACON Pharmaceuticals will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.73, which is the sum of squared deviations for the predicted TRACON Pharmaceuticals price change compared to its average price change.

About TRACON Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of TRACON Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of TRACON Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on TRACON Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding TRACON Pharmaceuticals. By analyzing TRACON Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of TRACON Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to TRACON Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 (projected)
Dividend Yield0.120.1
Price To Sales Ratio0.550.52

TRACON Pharmaceuticals March 28, 2024 Technical Indicators

Most technical analysis of TRACON help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for TRACON from various momentum indicators to cycle indicators. When you analyze TRACON charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether TRACON Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TRACON Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tracon Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tracon Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TRACON Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TRACON Stock, please use our How to Invest in TRACON Pharmaceuticals guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for TRACON Stock analysis

When running TRACON Pharmaceuticals' price analysis, check to measure TRACON Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TRACON Pharmaceuticals is operating at the current time. Most of TRACON Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of TRACON Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TRACON Pharmaceuticals' price. Additionally, you may evaluate how the addition of TRACON Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stocks Directory
Find actively traded stocks across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is TRACON Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TRACON Pharmaceuticals. If investors know TRACON will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TRACON Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.11)
Revenue Per Share
0.368
Return On Assets
(0.29)
Return On Equity
(12.77)
The market value of TRACON Pharmaceuticals is measured differently than its book value, which is the value of TRACON that is recorded on the company's balance sheet. Investors also form their own opinion of TRACON Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is TRACON Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TRACON Pharmaceuticals' market value can be influenced by many factors that don't directly affect TRACON Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TRACON Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if TRACON Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TRACON Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.